Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Blend Labs
BLND
$352M
| $2.46M | ﹤0.01% |
962,609
+255,349
| +36% | +$385K |
|
1827
Bank of Marin Bancorp
BMRC
$458M
| $2.45M | ﹤0.01% |
111,368
-20,439
| -16% | -$392K |
|
1828
Greif Class B
GEF.B
$4.2B
| $2.45M | ﹤0.01% |
37,100
-6,910
| -16% | -$457K |
|
1829
Nexa Resources
NEXA
$1.88B
| $2.45M | ﹤0.01% |
342,900
+31,400
| +10% | +$185K |
|
1830
Amplify Energy
AMPY
$198M
| $2.44M | ﹤0.01% |
412,300
+41,400
| +11% | +$267K |
|
1831
Vanguard High Dividend Yield ETF
VYM
$84B
| $2.44M | ﹤0.01% |
21,900
+17,100
| +356% | +$1.8M |
|
1832
Olema Pharmaceuticals
OLMA
$930M
| $2.44M | ﹤0.01% |
173,611
-136,889
| -44% | -$1.84M |
|
1833
BioAtla
BCAB
$5.13M
| $2.43M | ﹤0.01% |
19,750
+7,246
| +58% | +$628K |
|
1834
WisdomTree Japan Hedged Equity Fund
DXJ
$7.53B
| $2.43M | ﹤0.01% |
27,600
+11,800
| +75% | +$1.04M |
|
|
OMCC
1835
DELISTED
Old Market Capital Corp
OMCC
| $2.43M | ﹤0.01% |
351,951
-8,025
| -2% | -$45.9K |
|
1836
Castle Biosciences
CSTL
$905M
| $2.43M | ﹤0.01% |
112,400
+5,600
| +5% | +$98.6K |
|
1837
FirstEnergy
FE
$27.4B
| $2.42M | ﹤0.01% |
+66,008
| New | +$2.39M |
|
1838
Addus HomeCare
ADUS
$2.17B
| $2.41M | ﹤0.01% |
26,000
-52,500
| -67% | -$4.56M |
|
1839
abrdn Physical Silver Shares ETF
SIVR
$4.49B
| $2.4M | ﹤0.01% |
+105,600
| New | +$2.35M |
|
1840
DigitalBridge
DBRG
$2.94B
| $2.4M | ﹤0.01% |
+137,022
| New | +$2.26M |
|
1841
AerSale
ASLE
$280M
| $2.4M | ﹤0.01% |
+189,100
| New | +$2.74M |
|
1842
C4 Therapeutics
CCCC
$522M
| $2.4M | ﹤0.01% |
424,700
+66,712
| +19% | +$152K |
|
1843
PC Connection
CNXN
$2.05B
| $2.39M | ﹤0.01% |
35,500
+10,600
| +43% | +$631K |
|
|
UCTT
1844
Ultra Clean Holdings
UCTT
$3.85B
| $2.39M | ﹤0.01% |
69,900
-48,400
| -41% | -$1.35M |
|
1845
iShares Russell Top 200 Growth ETF
IWY
$16.7B
| $2.38M | ﹤0.01% |
+13,600
| New | +$2.23M |
|
|
ICVX
1846
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $2.38M | ﹤0.01% |
+151,200
| New | +$1.46M |
|
|
PHLT
1847
DELISTED
Performant Healthcare Inc
PHLT
| $2.38M | ﹤0.01% |
762,363
-26,700
| -3% | -$70K |
|
1848
Washington Trust Bancorp
WASH
$767M
| $2.38M | ﹤0.01% |
73,500
-22,768
| -24% | -$620K |
|
1849
SolarEdge
SEDG
$1.99B
| $2.38M | ﹤0.01% |
25,400
-82,700
| -77% | -$7.53M |
|
1850
Atmus Filtration Technologies
ATMU
$4.16B
| $2.37M | ﹤0.01% |
100,900
-106,700
| -51% | -$2.29M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.